MEGAN SOMMER: Open Payments
NPI 1013660760 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 73 payments from 22 companies in 2025. Trend: 2023 $103 · 2024 $0 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $303 |
| PFIZER INC. | 17 | $215 |
| Novo Nordisk Inc | 11 | $171 |
| Lilly USA, LLC | 10 | $167 |
| Ardelyx, Inc. | 4 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| ABBVIE INC. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: IBSRELA, FARXIGA, MOUNJARO, BREZTRI, NURTEC ODT, Ozempic, CAPLYTA, PREVNAR 20.
Industry payments across KS — which companies pay providers there.
